Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered region
暂无分享,去创建一个
B. Chait | W. Zhang | M. Di Virgilio | A. Donaldson | J. Garzón | M. Andreani | D. Rosen | T. Saha | A. Rahjouei | J. Andrade | S. Balasubramanian
[1] M. Di Virgilio,et al. Charting a DNA Repair Roadmap for Immunoglobulin Class Switch Recombination. , 2020, Trends in biochemical sciences.
[2] N. Gilbert,et al. The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress , 2020, eLife.
[3] A. Akalin,et al. PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification , 2020, The Journal of experimental medicine.
[4] A. Donaldson,et al. Checkpoint phosphorylation sites on budding yeast Rif1 protect nascent DNA from degradation by Sgs1-Dna2 , 2020, bioRxiv.
[5] D. Durocher,et al. SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus , 2020, EMBO reports.
[6] P. Sung,et al. The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication , 2020, Nature Reviews Molecular Cell Biology.
[7] DNA Double Strand Break , 2020, Definitions.
[8] Sandhya Balasubramanian,et al. 53BP1 Supports Immunoglobulin Class Switch Recombination Independently of Its DNA Double-Strand Break End Protection Function , 2019, Cell reports.
[9] A. Heijink,et al. RIF1 promotes replication fork protection and efficient restart to maintain genome stability , 2019, Nature Communications.
[10] N. Willis,et al. DNA double-strand break repair-pathway choice in somatic mammalian cells , 2019, Nature Reviews Molecular Cell Biology.
[11] M. Lopes,et al. Human RIF1-Protein Phosphatase 1 Prevents Degradation and Breakage of Nascent DNA on Replication Stalling , 2019, Cell reports.
[12] Alan M. Moses,et al. Proteome-wide signatures of function in highly diverged intrinsically disordered regions , 2019, bioRxiv.
[13] A. Smogorzewska,et al. Advances in understanding DNA processing and protection at stalled replication forks , 2019, The Journal of cell biology.
[14] B. Chait,et al. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination , 2018, Molecular cell.
[15] Christopher S. Hughes,et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.
[16] Y. Tabach,et al. SHLD2/FAM35A co‐operates with REV7 to coordinate DNA double‐strand break repair pathway choice , 2018, The EMBO journal.
[17] T. Helleday,et al. Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments , 2018, EMBO reports.
[18] S. Rottenberg,et al. 53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ , 2018, Nature.
[19] Anne-Claude Gingras,et al. The Shieldin complex mediates 53BP1-dependent DNA repair , 2018, Nature.
[20] Carlos Caldas,et al. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells , 2018, Nature Cell Biology.
[21] Chunaram Choudhary,et al. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity , 2018, Cell.
[22] K. Runge,et al. Rif1 phosphorylation site analysis in telomere length regulation and the response to damaged telomeres. , 2018, DNA repair.
[23] F. Alt,et al. DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions , 2018, Proceedings of the National Academy of Sciences.
[24] P. Pasero,et al. Nucleases Acting at Stalled Forks: How to Reboot the Replication Program with a Few Shortcuts. , 2017, Annual review of genetics.
[25] S. Jackson,et al. ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. , 2017, Molecular cell.
[26] M. Lieber,et al. Non-homologous DNA end joining and alternative pathways to double-strand break repair , 2017, Nature Reviews Molecular Cell Biology.
[27] J. Chaudhuri,et al. A transcriptional serenAID: the role of noncoding RNAs in class switch recombination , 2017, International immunology.
[28] G. Peng,et al. Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells , 2017, Oncogenesis.
[29] Alan M. Moses,et al. Selection maintains signaling function of a highly diverged intrinsically disordered region , 2017, Proceedings of the National Academy of Sciences.
[30] Yong-jie Xu,et al. The Cell Killing Mechanisms of Hydroxyurea , 2016, Genes.
[31] S. Cantor,et al. Replication Fork Stability Confers Chemoresistance in BRCA-deficient Cells , 2016, Nature.
[32] L. Symington. Mechanism and regulation of DNA end resection in eukaryotes , 2016, Critical reviews in biochemistry and molecular biology.
[33] J. Forman-Kay,et al. Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications , 2016, The Journal of Biological Chemistry.
[34] D. Cortez. Preventing replication fork collapse to maintain genome integrity. , 2015, DNA repair.
[35] Peter Bouwman,et al. REV7 counteracts DNA double-strand break resection and affects PARP inhibition , 2015, Nature.
[36] D. Durocher,et al. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end-resection , 2015, Nature.
[37] M. Lopes,et al. Replication fork reversal in eukaryotes: from dead end to dynamic response , 2015, Nature Reviews Molecular Cell Biology.
[38] A. Børglum,et al. Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells , 2015, Proceedings of the National Academy of Sciences.
[39] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[40] H. Dyson,et al. Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.
[41] L. Zou,et al. RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response , 2014, Cell Research.
[42] A. Donaldson,et al. At Short Telomeres Tel1 Directs Early Replication and Phosphorylates Rif1 , 2014, PLoS genetics.
[43] F. Alt,et al. 53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions , 2013, Cell.
[44] Lin Feng,et al. RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair* , 2013, The Journal of Biological Chemistry.
[45] Facundo D. Batista,et al. RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection , 2013, Molecular cell.
[46] Adam P. Rosebrock,et al. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. , 2013, Molecular cell.
[47] S. B. Buonomo,et al. 53BP1 Regulates DSB Repair Using Rif1 to Control 5′ End Resection , 2013, Science.
[48] Michel C. Nussenzweig,et al. Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching , 2013, Science.
[49] M. Nussenzweig,et al. RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. , 2013, Cell reports.
[50] Vishnu Dileep,et al. Mouse Rif1 is a key regulator of the replication‐timing programme in mammalian cells , 2012, The EMBO journal.
[51] S. Boulton,et al. Playing the end game: DNA double-strand break repair pathway choice. , 2012, Molecular cell.
[52] Hong Wu,et al. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. , 2012, Cancer cell.
[53] R. Mishra,et al. Functional diversification of yeast telomere associated protein, Rif1, in higher eukaryotes , 2012, BMC Genomics.
[54] Ty C. Voss,et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes , 2012, Nature.
[55] A. Egashira,et al. Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11 , 2011, Cell.
[56] Yves Pommier,et al. Rif1 provides a new DNA‐binding interface for the Bloom syndrome complex to maintain normal replication , 2010, The EMBO journal.
[57] A. Hyman,et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions , 2010, The Journal of cell biology.
[58] D. Adams,et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers , 2010, Nature Structural &Molecular Biology.
[59] Jeremy M. Stark,et al. 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.
[60] C. Deng,et al. A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. , 2009, Molecular cell.
[61] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[62] P. Borst,et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs , 2008, Proceedings of the National Academy of Sciences.
[63] Marcus B Smolka,et al. Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases , 2007, Proceedings of the National Academy of Sciences.
[64] Kengo Kinoshita,et al. PrDOS: prediction of disordered protein regions from amino acid sequence , 2007, Nucleic Acids Res..
[65] M. Nussenzweig,et al. Enhanced intra‐switch region recombination during immunoglobulin class switch recombination in 53BP1–/– B cells , 2007, European journal of immunology.
[66] J. Jonkers,et al. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects , 2006, Oncogene.
[67] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[68] Frank Eisenhaber,et al. Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. , 2004, Genes & development.
[69] Curtis C. Harris,et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis , 2001, Nature Genetics.
[70] Thomas Ried,et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.
[71] T. Honjo,et al. High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. , 1996, International immunology.
[72] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[73] J. D. Di Noia,et al. Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination. , 2017, Advances in immunology.
[74] Sang Eun Lee,et al. Classical and Alternative End Joining , 2014 .
[75] S. Ganesan,et al. Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. , 2013, Cancer discovery.
[76] F. Alt,et al. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. , 2012, Advances in immunology.
[77] M. Mann,et al. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.
[78] Ronald C Beavis,et al. Using the global proteome machine for protein identification. , 2006, Methods in molecular biology.